At the SLC6A14 locus on chromosome X, phase analysis uncovered a coordinated regulatory mechanism in which a promoter variant modulates lung phenotypes in individuals with CF when acting in cis with a lung-specific enhancer (E2765449/enhD). Here, SLC6A14 is linked to cystic fibrosis.